Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 21/54
Norm
Coleman
U.S. Senate · R-MN
Taken from pharma & insurers
$53,488
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 21/54
Pharma & Health$43,288
Insurers & HMOs$10,200
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 21 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$53,488
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Became a lobbyist with pharmaceutical and health clients at Hogan Lovells.
Source: OpenSecrets; LegiStorm
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$43,288
Johnson & Johnson$33,798
Eli Lilly$2,500
Merck$2,300
PhRMA$2,000
Amgen$1,550
Pfizer$640
Bristol Myers Squibb$500
Insurers & HMOs$10,200
UnitedHealth$4,700
Cigna$2,500
Humana$1,500
Aetna$1,500